NeueHealth (NYSE:NEUE) versus Trupanion (NASDAQ:TRUP) Head to Head Contrast

NeueHealth (NYSE:NEUE) and Trupanion (NASDAQ:TRUP) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings.

Earnings and Valuation

This table compares NeueHealth and Trupanion’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeueHealth	$1.16 billion	0.04	-$1.15 billion	($151.20)	-0.04
Trupanion	$1.11 billion	0.81	-$44.69 million	($1.08)	-19.78

Trupanion has lower revenue, but higher earnings than NeueHealth. Trupanion is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

NeueHealth has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, Trupanion has a beta of 1.71, meaning that its stock price is 71% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for NeueHealth and Trupanion, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
Trupanion	0	3	1	0	2.25

NeueHealth presently has a consensus price target of $8.00, indicating a potential upside of 26.78%. Trupanion has a consensus price target of $33.20, indicating a potential upside of 55.43%. Given Trupanion’s stronger consensus rating and higher probable upside, analysts plainly believe Trupanion is more favorable than NeueHealth.

Insider and Institutional Ownership

63.9% of NeueHealth shares are owned by institutional investors. 64.3% of NeueHealth shares are owned by company insiders. Comparatively, 5.8% of Trupanion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares NeueHealth and Trupanion’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
Trupanion	-4.03%	-15.19%	-5.95%

Summary

Trupanion beats NeueHealth on 8 of the 14 factors compared between the two stocks.

About NeueHealth

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

About Trupanion

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.